Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
about
Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipidsT cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individualsImmunologic and hematologic properties of antibodies to prothrombin and plasminogen in a mouse model.Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels.Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.Hyperactivity in a mouse model of the antiphospholipid syndrome.Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model.The systemic nature of the antiphospholipid syndrome.Are antiphospholipid antibodies an essential requirement for an effective immune response to infections?Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome.β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.Accelerated atheroma and anti-beta2-glycoprotein I antibodies.Association of anticardiolipin antibodies with vascular injury: possible mechanisms.Human apolipoprotein H may have various orientations when attached to lipid layer.Induction and treatment of the antiphospholipid syndrome--lessons from animal models.Multiple autoantibodies associated with autoimmune reproductive failureAnti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries.The molecular basis of antiphospholipid syndrome.Autoantibodies associated with reproductive failure.Antiphosphatidylserine antibodies and reproductive failure.Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.Immunomodulation of experimental APS: lessons from murine models.β2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus.The insertion of human apolipoprotein H into phospholipid membranes: a monolayer study.Expression of apoptosis in placenta of experimental antiphospholipid syndrome mouse.Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo.Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies.Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.Systemic antiphospholipid syndrome.Relationship Between Fetal Loss and Serum Gonadal Hormones Level in Experimental Antiphospholipid Syndrome Mouse.TNFalpha DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome.Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies.
P2860
Q24561680-D2A92A3E-AB26-42C5-A9CF-8A51B890F47BQ28143036-68B74779-BC36-4BA6-A176-2B6FA2098E04Q32119088-EF4582E7-5A08-48BA-B1E8-796E1ED7E598Q33328443-C6ADFB07-3B7A-4816-AF82-E088DA487813Q33329907-61FDF393-EEA9-431B-9A8E-8CF84AF732C7Q33338363-E3644960-8749-48E4-A6B5-E807DB979E42Q33341518-D5F56B0E-383F-48AA-AC7D-FA19D9599333Q33348155-BBD459B4-5DAA-43A3-8A3E-B555AF512980Q33365607-6CB06669-AE3A-4A14-9052-5BA1C078A444Q33376794-77554CF8-2FD2-40A1-938B-AEF672E6870FQ33394044-8A72BD9D-BA6E-4EDA-B138-77D14EE5E92DQ33496557-11467777-3BD6-4B80-8D05-08DA73934246Q33497584-E46359C0-CE91-479A-AF76-BE7772086AE7Q33796355-79CE33C0-04DB-4BD9-A4BD-DEEC34A2E568Q33915467-ACA2F252-9CCF-4B49-BFE8-FC8669097909Q34048278-34CC3C9D-C685-42B5-A18F-DBEE222E16FDQ34178498-443C66A6-E788-4DED-9EE5-911B4F1ED01AQ34319733-2C765F0C-09B2-4771-B268-B7376F0DA629Q35104548-FB7490E0-DA11-4481-85F7-C3C653A3C142Q35167094-0949F3CC-40EB-47A4-B836-3621157DD499Q35208178-4EC2FD0B-9EC9-49DE-9C5F-B8673AD633DDQ35918355-89257FD7-A3A5-4EA4-970D-F844130A4FE2Q35918365-71A2FE63-A37F-44A5-AD3E-F18D6E833675Q36087118-B27B0333-670A-4168-9DB4-7AE415ACE551Q36222874-05A8CBB0-5CC2-497D-8F11-1D38AD7A189AQ36227184-7B672CC4-6C36-42AB-81AF-CFEF231029D5Q36799474-B8CE7074-8145-4FCD-9195-03315E3F6D2EQ40529769-AA75E1C7-2C1D-41F0-89D4-02D385294072Q41197490-CB689104-E355-4AAE-B316-700183D57E0EQ41375519-BA1D0E24-D5AD-47D5-954B-4E52CC68A154Q42224647-EC86F9C1-7C3A-4068-8110-3E63CC97DC10Q43446086-C95327CC-203C-4D26-8BFB-D16FCA7AF590Q43882937-06D555FF-7EE8-4DFC-9A38-D5AEC601F85EQ44428099-4A0325C8-951C-4D7A-BA8F-A9545C40FB60Q45077755-97F0DB62-CFF5-48F1-B0D9-08950B6170E0Q47975768-4907708E-FF2B-4BDC-8D6D-FA96E1C870D1Q48238011-E3D24B23-BE75-44C5-9FB9-7018380B414CQ50200213-6A96B8B6-043E-45BA-8955-0D09A24A02ABQ52006433-A3926085-A6D5-4CD1-B1E6-80ED26A343D2Q52008946-ACAA8EF0-9935-4112-A455-19E0CAFB6FB8
P2860
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Immunization with anticardioli ...... olipid syndrome in naive mice.
@ast
Immunization with anticardioli ...... olipid syndrome in naive mice.
@en
type
label
Immunization with anticardioli ...... olipid syndrome in naive mice.
@ast
Immunization with anticardioli ...... olipid syndrome in naive mice.
@en
prefLabel
Immunization with anticardioli ...... olipid syndrome in naive mice.
@ast
Immunization with anticardioli ...... olipid syndrome in naive mice.
@en
P2093
P50
P356
P1476
Immunization with anticardioli ...... olipid syndrome in naive mice.
@en
P2093
Balestrieri G
Goldberg I
Kopolovic J
P304
P356
10.1006/JAUT.1994.1032
P577
1994-08-01T00:00:00Z